e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Novel in vitro and animal models to study lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of compensatory induction of various PTEN mutants against TGFbeta-induced translocation of beta-catenin in lung cancer cells
M. Kusunose, N. Hashimoto, D. Aoyama, Y. Hasegawa (Nagoya-city, Japan)
Source:
Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Session:
Novel in vitro and animal models to study lung diseases
Session type:
Thematic Poster Session
Number:
522
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Kusunose, N. Hashimoto, D. Aoyama, Y. Hasegawa (Nagoya-city, Japan). The effect of compensatory induction of various PTEN mutants against TGFbeta-induced translocation of beta-catenin in lung cancer cells. Eur Respir J 2013; 42: Suppl. 57, 522
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Translocation of beta-catenin into cytoplasm during TGFbeta-induced EMT is negatively regulated by phosphorylation of the PTEN C-terminus in lung cancers
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Inhibition of hypoxia-induced phenotype alterations through epithelial-mesenchymal transition (EMT) in lung cancer by gene modulation of phosphorylation sites in tumor suppressor PTEN
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Comprehensive analysis of the PTEN domains on TGFbeta-induced aberrant cell motility in lung alveolar/epithelial cells by using PTEN constructs with deletion mutants
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Placenta growth factor promotes autophagy in lung epithelial cell through JNK and p38 MAPK pathway
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
WNT5A antagonizes canonical WNT/beta-catenin signaling in lung epithelial cells
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
GSK-3 inhibition suppresses lung cancer cell survival, metastasis and proliferation through down-regulation the phosphorylation sites of CAP1
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Depletion of STAT6 suppresses lung cancer progression through regulating M2-macrophage polarization
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
Effects of p27Kip1 on cell cycle status and viability in A549 lung adenocarcinoma cells
Source: Eur Respir J 2004; 23: 665-670
Year: 2004
Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines
Source: Eur Respir J 2004; 24: Suppl. 48, 5s
Year: 2004
Bile acid receptor accelerates to the lung cancer process induced by lung fibroblast-tumor cells interaction, with high activation of phosphorylated STAT3 and alteration of cytokine secretion
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Involvement of proteasome inhibition and p53 accumulation in epithelial apoptosis of lung injury
Source: Eur Respir J 2005; 26: Suppl. 49, 101s
Year: 2005
SIRT6-induced activation of autophagy inhibits CSE-induced bronchial epithelial cell senescence
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013
Cell physiological role of HIF-1a and PTEN in adenocarcinoma cells in normoxia/hypoxia
Source: Eur Respir J 2002; 20: Suppl. 38, 13s
Year: 2002
Targeting the mTOR signaling pathway to inhibit lung cell senescence in COPD
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Cell cycle regulation of IPF-derived lung fibroblasts is dependent on RhoA signalling
Source: Eur Respir J 2005; 26: Suppl. 49, 102s
Year: 2005
ATF3 regulates PINK1 transcription in lung epithelial cells of the aging lung
Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung
Year: 2016
Caspase recruitment domain containing protein 9 suppresses non-small cell lung cancer proliferation and invasion via inhibiting MAPK/p38 pathway
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Axl receptor tyrosine kinase drives cell cycle re-entry and promotes symmetric cell division of airway basal cells in response to injury
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
Disruption of the HIF-1 pathway in cancer cells
Source: Research Seminar 2005 - Adaptations to Hypoxia
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept